ASTRO highlights Winship study showing increased failure-free survival in prostate cancer

(Emory Health Sciences) The EMPIRE-1 trial is the first randomized trial of men with prostate cancer with recurring cancer to show that treatment based on advanced molecular imaging can improve disease-free survival rates.